
Orion reports strong H1 2026 with 22% revenue growth and raises full-year outlook
Orion Oyj posted a 21.8% revenue increase to €939.3 million and a 59.6% rise in operating profit to €291.3 million for the first half of 2026. The company highlighted progress in its ODM-212 cancer drug development and FDA approval for its Animal Hea...

